These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26349635)

  • 1. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children.
    Tantikul C; Dhana N; Jongjarearnprasert K; Visitsunthorn N; Vichyanond P; Jirapongsananuruk O
    Asian Pac J Allergy Immunol; 2008; 26(2-3):77-82. PubMed ID: 19054924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and preliminary validation of an instrument to enable laypersons to assess suspected side effects from medicines.
    O'Donovan B; Rodgers RM; Cox AR; Krska J
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):1023-1031. PubMed ID: 31197912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study.
    Kampichit S; Srisuriyachanchai W; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2024 Apr; 46(2):401-410. PubMed ID: 38151687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidence and accuracy in identification of adverse drug reactions reported by outpatients.
    Kampichit S; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2018 Dec; 40(6):1559-1567. PubMed ID: 30367372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.
    Jarernsiripornkul N; Chaisrisawadsuk S; Chaiyakum A; Krska J
    Pharm World Sci; 2009 Oct; 31(5):559-564. PubMed ID: 19575308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of patients' experiences and their certainty of suspected adverse drug reactions.
    Narumol J; Arunrot P; Krska J
    Int J Clin Pharm; 2015 Feb; 37(1):168-74. PubMed ID: 25576461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
    Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
    Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Drug Reactions at Nonelective Hospital Admission in Children and Adolescents: Comparison of 4 Causality Assessment Methods.
    Neininger MP; Wehr R; Kiesel LM; Neubert A; Kiess W; Bertsche A; Bertsche T
    J Patient Saf; 2022 Jun; 18(4):318-324. PubMed ID: 35617590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two methods to assess causality of adverse drug reactions].
    Kyonen M; Folatre I; Lagos X; Vargas S
    Rev Med Chil; 2015 Jul; 143(7):880-6. PubMed ID: 26361025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.